In order to strengthen their positions in the worldwide interventional intracranial aneurysm market, market participants are employing inorganic development strategies, such as collaborations. The market for devices to treat cerebral aneurysms is anticipated to develop as a result throughout the forecast period. For instance, in June 2022, the global medical technology company Stryker announced a collaboration with the Swedish medical device manufacturer Carmeda AB to treat brain aneurysms using a combination of Stryker's tried-and-true flow diverter technology and Carmeda's active heparin coating. The development of technologically advanced products and surgical techniques for the treatment of brain or intracranial aneurysms by research and academic institutions is anticipated to boost the growth of the worldwide interventional intracranial aneurysm devices market over the forecast period. For instance, in May 2021, a research team from the South Korean university Pohang University of Science and Technology (POSTECH) created a unique technique for injecting blood into aneurysms that can prevent blood vessels from rupturing. To overcome the limitations of coil embolisation, the multidisciplinary research team at POSTECH developed a unique structurally stable, biocompatible embolisation material that does not deteriorate in the human body.
According to Coherent Market Insights, The market for Interventional Intracranial Aneurysm Devices is projected to reach US$ 3,670.34 Mn in 2022 and is anticipated to grow at a CAGR of 7.7% from 2022 to 2030.
Major Players in the Interventional Intracranial Aneurysm Devices Industry:
1. MicroPort Scientific Corporation
The firm was founded in 1998 and is based in China. The business creates minimally invasive and interventional surgical tools. In addition to creating treatments to treat diabetic and orthopaedic ailments, the company's goods are utilised to treat vascular illnesses.
2. B. Braun SE
The company was founded in 1839 and has its main office in Melsungen, Germany. The business sells instruments, trocar systems, ligation clips, light sources, anaesthesia tools, electrosurgical, suction, and equipment for wound closure, blood glucose monitoring, and insulin injection. B. Braun purchased Intermedt Medizin & Technik GmbH, an expert in the creation of dialysis concentrates, in March 2022.
3. Stryker
The company was started in 1941 and is located in Kalamazoo, Michigan, United States. The Stryker Corporation creates, produces, and sells specialised surgical and healthcare products. The corporation announced in January 2022 that it will purchase Vocera Communications, a digital care company, for about $3 billion. Stryker announced in January 2021 that it will buy OrthoSensor, Inc., a joint replacement technology company.
4. MicroVention Inc.
The business was founded in 1997 and is based in California, United States. The business creates catheter-based, minimally invasive neuro-endovascular treatments for conditions such as cerebral aneurysms and other neurovascular disorders. MicroVention announced in February 2022 that a patient has been successfully treated with the FRED X flow diverter using X technology.
5. Johnson & Johnson Private Limited
The company was founded in 1957 and is based in New Brunswick, New Jersey. The business produces medical supplies and offers related services to the consumer, pharmaceutical, medical device, and diagnostics industries. In addition to selling medications, surgical equipment, diagnostic tools, and paracetamol products internationally, the company also provides skin and hair care items.
6. Terumo Corporation
The company was started in 1921 and is based in Tokyo, Japan. Pharmaceuticals, medical devices, and equipment are all produced and supplied by Terumo Corporation. The company sells artificial organs, clinical testing systems, health foods, electronic thermometers, disposable medical supplies, and transfusion and infusion equipment.
7. Medtronic
The firm was started in 1949 and is based in Minneapolis, Minnesota. It creates and produces medical treatments and technologies. The business announced its intent to purchase Stimgenics, LLC and their main therapy in January 2020. The company declared in January 2022 that it will buy Affera, Inc. A contract between Medtronic and healthcare performance improvement firm Vizient was revealed in March.
Definition: A weakening of the inner muscle layer of a blood vessel wall causes an interventional intracranial aneurysm, which is a rare central dilatation of an artery in the brain. The brain may bleed if an intracranial aneurysm ruptures.
